Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2003-01-15 (23 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAVIGNE-L'EVEQUE (72460), Sarthe
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE LABARRIERE CHEYMOL : revenue, balance sheet and financial ratios
PHARMACIE LABARRIERE CHEYMOL is a French company
founded 23 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAVIGNE-L'EVEQUE (72460),
this company of category PME
shows in 2022 a revenue of 4.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE LABARRIERE CHEYMOL (SIREN 445017676)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
4 612 964 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
203 644 €
192 866 €
283 406 €
213 365 €
206 912 €
172 049 €
63 984 €
40 795 €
21 763 €
EBITDA
N/C
N/C
411 317 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
6.1%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE LABARRIERE CHEYMOL generates positive net income of 204 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 22 k€ -> 204 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
203 644 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 18%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 62%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
17.627%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
62.251%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
196.527
162.829
149.184
117.172
86.606
60.707
41.259
26.028
17.627
Financial autonomy
26.703
28.915
31.104
35.439
41.236
46.323
53.544
58.832
62.251
Repayment capacity
None
None
None
None
None
None
1.749
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
6.247%
None%
None%
Sector positioning
Debt ratio
17.632024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good-8 pts over 3 years
In 2024, the debt ratio of PHARMACIE LABARRIERE CHEYMOL (17.63) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
62.25%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+8 pts over 3 years
In 2024, the financial autonomy of PHARMACIE LABARRIERE CHEYMOL (62.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
1.75 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good
In 2022, the repayment capacity of PHARMACIE LABARRIERE CHEYMOL (1.75) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 154.94. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
100.733
91.353
104.134
124.114
139.776
140.525
159.919
152.413
154.943
Interest coverage
None
None
None
None
None
None
2.434
None
None
Sector positioning
Liquidity ratio
154.942024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average+5 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE LABARRIERE CHEYMOL (154.94) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
2.43x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of PHARMACIE LABARRIERE CHEYMOL (2.4x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE LABARRIERE CHEYMOL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
342 051 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
29
0
0
Customer payment term (days)
0
0
0
0
0
0
4
0
0
Supplier payment term (days)
0
0
0
0
0
0
45
0
0
Positioning of PHARMACIE LABARRIERE CHEYMOL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE LABARRIERE CHEYMOL is estimated at
2 843 020 €
(range 1 979 834€ - 4 253 321€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1979k€2843k€4253k€
2 843 020 €Range: 1 979 834€ - 4 253 321€
NAF 5 année 2024
Valuation method used
Net Income Multiple
203 644 €
×
14.0x
=2 843 021 €
Range: 1 979 835€ - 4 253 322€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE LABARRIERE CHEYMOL with other companies in the same sector:
Frequently asked questions about PHARMACIE LABARRIERE CHEYMOL
What is the revenue of PHARMACIE LABARRIERE CHEYMOL ?
The revenue of PHARMACIE LABARRIERE CHEYMOL in 2022 is 4.6 M€.
Is PHARMACIE LABARRIERE CHEYMOL profitable?
Yes, PHARMACIE LABARRIERE CHEYMOL generated a net profit of 204 k€ in 2024.
Where is the headquarters of PHARMACIE LABARRIERE CHEYMOL ?
The headquarters of PHARMACIE LABARRIERE CHEYMOL is located in SAVIGNE-L'EVEQUE (72460), in the department Sarthe.
Where to find the tax return of PHARMACIE LABARRIERE CHEYMOL ?
The tax return of PHARMACIE LABARRIERE CHEYMOL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE LABARRIERE CHEYMOL operate?
PHARMACIE LABARRIERE CHEYMOL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart